The Role of Elacestrant in ER+/HER2– Advanced Breast Cancer Harboring ESR1 Mutations | OncLive
The Role of Elacestrant in ER+/HER2– Advanced Breast Can…
1 month ago
onclive.com
Phase 3 EMERALD Study of Elacestrant | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Phase 3 EMERALD Study of Elacestrant | Targeted Oncology - …
7 months ago
targetedonc.com
The Role of Elacestrant in Breast Cancer | OncLive
The Role of Elacestrant in Breast Cancer | OncLive
Jan 30, 2024
onclive.com
The EMERALD Trial: Elacestrant in Patients with HR , HER2- Advanced Breast Cancer | OncLive
The EMERALD Trial: Elacestrant in Patients with HR , HER2- Advance…
Feb 9, 2024
onclive.com
EMERALD subgroup analysis: Elacestrant in endocrine-sensitive disease | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
EMERALD subgroup analysis: Elacestrant in endocrine-sensitiv…
Nov 25, 2024
targetedonc.com
Elacestrant Targeted Therapy for ER /HER2– Metastatic Breast Cancer: Early Phase Trial Findings | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Elacestrant Targeted Therapy for ER /HER2– Metastatic Breast Cancer: …
Jul 3, 2024
targetedonc.com
EMERALD: Elacestrant in ER /HER2- Advanced Breast Cancer | OncLive
EMERALD: Elacestrant in ER /HER2- Advanced Breast Cancer | OncLive
Jan 23, 2024
onclive.com
1:07
Tumori: oncologa Del Mastro, 'elacestrant passo avanti in cura c…
2 weeks ago
MSNAdnkronos
Advanced HR+ BC: Elacestrant vs. ET, Alpelisib/Inavolisib for PIK3CA…
284 viewsMar 4, 2024
vumedi.com
ER+ metastatic breast cancer: Key insights on elacestrant from the la…
10 months ago
apple.com
2:01
Real-World Data Reveal Longer PFS With Elacestrant in Breast Cancer …
1 week ago
targetedonc.com
Dr. Bardia on Elacestrant in ER+/HER2– Metastatic Breast Can…
6 days ago
onclive.com
The EMERALD Trial: Elacestrant Mechanism of Action, Study Desig…
Nov 9, 2022
targetedonc.com
Tumore: elacestrant nuova terapia in aiuto a pazienti con carcinoma …
Jun 20, 2024
Il Sole 24 ORE
Considering Elacestrant in ESR1 Breast Cancer After CDK4/6 Inhibi…
1 year ago
targetedonc.com
SABCS 2024 Insights: Impact of Prior Treatment, ESR1 Mutations, …
191 viewsDec 17, 2024
vumedi.com
Dr. Lin on the Advantage of Elacestrant in ESR1-Mutated Brea…
Jun 14, 2022
onclive.com
1:44
Dr Rugo on Elacestrant-Based Combinations in ER /HER2– Metas…
Dec 11, 2024
onclive.com
0:58
1.5K views · 142 reactions | 溺 C’è un nuovo farmaco per il tumore al...
2.7K views2 weeks ago
FacebookDott. Jonathan Granatieri - Farmacista
Dr. Bidard on the FDA Approval of Elacestrant in ER /HER2– Metastat…
Feb 8, 2023
onclive.com
EMERALD Phase 3 Trial of Elacestrant Versus Standard of Ca…
Dec 22, 2022
onclive.com
6:07
Elacestrant real-world progression-free survival (rwPFS) of adult patie…
Dec 18, 2024
onclive.com
0:50
Elacestrant - Not Just for ESR1 Mutations
4 views1 month ago
YouTubeLiveFromStage4 Podcast
9:11
Perspectives on a Patient with ESR1m and PIK3CA Mutations
3 weeks ago
YouTubeORSERDU® (elacestrant) HCP
10:00
Advances in HR+ Breast Cancer: CDK4/6 Inhibitors and Oral SERD…
1 month ago
YouTubeCõi Tịnh - Lời Phật Dạy
0:41
Oral SERDs Impacting Breast Cancer Treatment #shorts
320 views3 weeks ago
YouTubeCancer Treatment Updates
0:34
Elacestrant
64 views2 months ago
YouTubeDr Nitika Pharmacology discussion
0:23
New Breast Cancer Drug Extends Lives: Elacestrant & Emlunestran…
799 views1 month ago
YouTubeCancer Treatment Updates
0:49
OncoAlert on Instagram: "The #OncoAlertColloquium 2026 Breas…
399 views1 week ago
Instagramoncoalert
See more videos
Static thumbnail place holder